Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In all malarious areas, infection by any of the main human plasmodial species during pregnancy is detrimental to the mother and the fetus. These potentially fatal infections must be prevented, but when they develop they require prompt diagnosis and treatment. Current tools to detect malaria parasites in pregnant women are often not used and remain too insensitive to detect a low parasitaemia. The kinetics, safety, and efficacy of available antimalarial drugs are poorly documented because pregnant women are systematically excluded from clinical trials. A considerable effort, involving clinical trials, is urgently required to improve the diagnosis and case management of malaria during pregnancy if the morbidity and mortality of maternal malaria is to be reduced.

Original publication

DOI

10.1016/S1473-3099(07)70023-3

Type

Journal article

Journal

Lancet Infect Dis

Publication Date

02/2007

Volume

7

Pages

118 - 125

Keywords

Adult, Animals, Antimalarials, Female, Humans, Malaria, Malaria, Falciparum, Pregnancy, Pregnancy Complications, Parasitic